Tarloxotinib Bromide | Interleukin Related interleukin-related.com

Product Name :
Tarloxotinib Bromide

Search keywords :
Tarloxotinib (bromide)

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-4

Target Vo Short Name :
HER4

Moa_Name:
Receptor protein-tyrosine kinase erbB-4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Threshold

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-4E BP1 (Thr46) Rabbit mAb Cancer
Bavituximab Biological Activity
Cdk2 Antibody: Cdk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts